{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:59:39Z","timestamp":1777687179544,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2017,6,30]]},"DOI":"10.3233\/jhd-170234","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T14:47:30Z","timestamp":1495810050000},"page":"139-147","source":"Crossref","is-referenced-by-count":4,"title":["Assessing Decline: Visualising Progression in Huntington\u2019s Disease using a Clinical Dashboard with Enroll-HD Data"],"prefix":"10.1177","volume":"6","author":[{"given":"Thomas","family":"Walker","sequence":"first","affiliation":[{"name":"Clinical Neurosciences, University ofSouthampton, Life Sciences Building, Highfield Campus, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyd","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University ofSouthampton, Life Sciences Building, Highfield Campus, Southampton, UK"},{"name":"Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kipps","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University ofSouthampton, Life Sciences Building, Highfield Campus, Southampton, UK"},{"name":"Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK"},{"name":"Wessex NIHR CLAHRC, University ofSouthampton, Life Sciences Building, Highfield Campus, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JHD-170234_ref1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1108\/CGIJ-06-2015-0019","article-title":"Clinical dashboards and their use in an adult mental health inpatient setting, a pilot study","volume":"20","author":"Phull","year":"2015","journal-title":"Clin Gov"},{"key":"10.3233\/JHD-170234_ref2","first-page":"1098","article-title":"Designing a clinical dashboard to fill information gaps in the emergency department","volume":"2014","author":"Swartz","year":"2014","journal-title":"AMIA Annu Symp Proc"},{"key":"10.3233\/JHD-170234_ref3","doi-asserted-by":"crossref","unstructured":"Staib A , Sullivan C , Jones M , Griffin B , Bell A , Scott I . The ED-inpatient dashboard: Uniting emergency and inpatient clinicians to improve the efficiency and quality of care for patients requiring emergency admission to hospital. Emerg Med Australas. 2016. doi: 10.1111\/1742-6723.12661","DOI":"10.1111\/1742-6723.12661"},{"issue":"7","key":"10.3233\/JHD-170234_ref4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7196\/SAMJnew.7764","article-title":"Impact of an educational intervention and clinical performance dashboard on neonatal bloodstream infections","volume":"105","author":"Raban","year":"2015","journal-title":"S Afr Med J"},{"issue":"2","key":"10.3233\/JHD-170234_ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4038\/cmj.v61i2.8291","article-title":"The role of clinical dashboards in improving patient care: Experience with the \u2018Maternity Dashboard\u2019","volume":"61","author":"Chandraharan","year":"2016","journal-title":"Ceylon Med J"},{"key":"10.3233\/JHD-170234_ref7","unstructured":"Johnson J . Designing with the Mind in Mind: Simple Guide to Understanding User Interface Design Rules. Massachusetts, USA Morgan Kaufmann; 2010."},{"issue":"5","key":"10.3233\/JHD-170234_ref8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1258\/cr.2010.010022","article-title":"Clinical dashboards: Do they actually work in practice? Three-year experience with the Maternity Dashboard","volume":"16","author":"Chandraharan","year":"2010","journal-title":"Clin Risk"},{"issue":"9","key":"10.3233\/JHD-170234_ref9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-170234_ref10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"issue":"6","key":"10.3233\/JHD-170234_ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/13803390903313564","article-title":"Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status","volume":"32","author":"Beglinger","year":"2010","journal-title":"J Clin Exp Neuropsychol"},{"issue":"10","key":"10.3233\/JHD-170234_ref12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/jnnp-2014-308153","article-title":"Modelling the natural history of Huntington\u2019s disease progression","volume":"86","author":"Kuan","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-170234_ref13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.46.2.527","article-title":"Trinucleotide repeat length and clinical progression in Huntington\u2019s disease","volume":"46","author":"Brandt","year":"1996","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JHD-170234_ref14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/mds.21988","article-title":"The relationship between CAG repeat length and clinical progression in Huntington\u2019s disease","volume":"23","author":"Ravina","year":"2008","journal-title":"Mov Disord"},{"issue":"7","key":"10.3233\/JHD-170234_ref15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"10.3233\/JHD-170234_ref16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington\u2019s disease: Clinical correlates of disability and progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.3233\/JHD-170234_ref17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.31.11.872","article-title":"Trinucleotide repeat length and progression of illnessin Huntington\u2019s disease","volume":"31","author":"Kieburtz","year":"1994","journal-title":"J Med Genet"},{"issue":"3","key":"10.3233\/JHD-170234_ref18","first-page":"e010579","article-title":"EHDViz: Clinicaldashboard development using open-source technologies","volume":"6","author":"Badgeley","year":"2016","journal-title":"BMJOpen"},{"issue":"5","key":"10.3233\/JHD-170234_ref19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1208\/s12248-014-9632-5","article-title":"Dashboard systems:Implementing pharmacometrics from bench to bedside","volume":"16","author":"Mould","year":"2014","journal-title":"AAPS J"},{"key":"10.3233\/JHD-170234_ref21","doi-asserted-by":"crossref","unstructured":"Unified Huntington\u2019s Disease Rating Scale: Reliability and consistency. Mov Disord. 1996;11(2):136\u201342.","DOI":"10.1002\/mds.870110204"},{"issue":"3","key":"10.3233\/JHD-170234_ref22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25657","article-title":"Tracking motor impairments in the progression of Huntington\u2019s disease","volume":"29","author":"Long","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-170234_ref23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch Neurol"},{"issue":"12","key":"10.3233\/JHD-170234_ref24","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.3233\/JHD-170234_ref25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00415-004-0461-9","article-title":"Cognitive changes in patients with Huntington\u2019s disease (HD) and asymptomatic carriers of the HD mutation\u2013a longitudinal follow-up study","volume":"251","author":"Lemiere","year":"2004","journal-title":"J Neurol"},{"issue":"9","key":"10.3233\/JHD-170234_ref26","doi-asserted-by":"crossref","first-page":"e74486","DOI":"10.1371\/journal.pone.0074486","article-title":"A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy","volume":"8","author":"Ghosh","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JHD-170234_ref27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pnp.186","article-title":"Working together: A one-stop shop for Huntington\u2019s disease","volume":"15","author":"El-Nimr","year":"2011","journal-title":"Prog Neurol Psychiatry"},{"key":"10.3233\/JHD-170234_ref28","doi-asserted-by":"crossref","unstructured":"Fox SH , Brotchie JM . Levodopa-induced dyskinesia in Parkinson\u2019s disease. New York City, USA: Springer; 2014.","DOI":"10.1007\/978-1-4471-6503-3"},{"issue":"3-4","key":"10.3233\/JHD-170234_ref29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000367628","article-title":"Reliability of clinical diagnosis of dystonia","volume":"43","author":"Beghi","year":"2014","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JHD-170234_ref30","doi-asserted-by":"crossref","first-page":"e2530","DOI":"10.7717\/peerj.2530","article-title":"Hypernasalityassociated with basal ganglia dysfunction: Evidence fromParkinson\u2019s disease and Huntington\u2019s disease","volume":"4","author":"Novotn\u00fd","year":"2016","journal-title":"Peer J"},{"issue":"1","key":"10.3233\/JHD-170234_ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/jocn.1998.0151","article-title":"Huntington\u2019s disease: Neurological assessment of potential genecarriers presenting for predictive DNA testing","volume":"7","author":"McCusker","year":"2000","journal-title":"J Clin Neurosci"},{"issue":"8","key":"10.3233\/JHD-170234_ref32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington\u2019s disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch Neurol"},{"issue":"2","key":"10.3233\/JHD-170234_ref33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JHD-150143","article-title":"Antidopaminergic medication is associated with more rapidly progressive Huntington\u2019s disease","volume":"4","author":"Tedroff","year":"2015","journal-title":"J Huntingtons Dis"},{"issue":"3","key":"10.3233\/JHD-170234_ref34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington\u2019s disease","volume":"162","author":"Consortium GMoHsDG-H","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.3233\/JHD-170234_ref35","doi-asserted-by":"crossref","first-page":"e0161106","DOI":"10.1371\/journal.pone.0161106","article-title":"COMT Val158Met polymorphism modulates Huntington\u2019s disease progression","volume":"11","author":"de Diego-Balaguer","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.3233\/JHD-170234_ref36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1310\/hpj4905-485","article-title":"Health System Dashboard: It\u2019s all coming together","volume":"49","author":"Felkey","year":"2014","journal-title":"Hosp Pharm"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-170234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:17Z","timestamp":1777453037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-170234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":34,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-170234","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]}}}